Page last updated: 2024-11-04

sulforaphane and Acute Myelogenous Leukemia

sulforaphane has been researched along with Acute Myelogenous Leukemia in 3 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Wang, F1
Huang, X1
Sun, Y1
Li, Z1
Sun, R1
Zhao, T1
Wang, M1
Yan, C1
Liu, P1
Wang, FP1
Qiao, CJ1
Sun, YW1
Li, XY1
Huang, XY1
Zhang, WR1
Wang, X1
Wang, MY1
Koolivand, M1
Ansari, M1
Piroozian, F1
Moein, S1
MalekZadeh, K1

Other Studies

3 other studies available for sulforaphane and Acute Myelogenous Leukemia

ArticleYear
Sulforaphane regulates the proliferation of leukemia stem-like cells via Sonic Hedgehog signaling pathway.
    European journal of pharmacology, 2022, Mar-15, Volume: 919

    Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Hedgehog Proteins; Humans; I

2022
[Effect and Mechanism of Sulforaphane on G
    Zhongguo shi yan xue ye xue za zhi, 2021, Volume: 29, Issue:4

    Topics: Cell Cycle; Humans; Isothiocyanates; Leukemia, Myeloid, Acute; Mitosis; Sulfoxides

2021
Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels.
    Molecular biology reports, 2018, Volume: 45, Issue:6

    Topics: Adolescent; Adult; Aged; Apoptosis; Biomarkers, Tumor; Cell Differentiation; Cell Line, Tumor; Child

2018